Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced

Vistagen Therapeutics, Inc. (VTGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 2,788,620 options to buy @ $0.001, valued at $2.8k
Granted 1,394,310 options to buy @ $5.38, valued at $7.5M
Granted 1,690,014 options to buy @ $8.877, valued at $15M
08/23/2023 4 Anderson Cynthia Lynn (CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $5.34, valued at $44.5k
08/23/2023 3 Anderson Cynthia Lynn (CFO) has filed a Form 3 on Vistagen Therapeutics, Inc.
08/09/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Bought 775,756 shares @ $23.153, valued at $18M
08/09/2023 3 COMMODORE CAPITAL LP (10% Owner) has filed a Form 3 on Vistagen Therapeutics, Inc.
07/05/2023 4 Singh Shawn (CEO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
07/05/2023 4 Adler Reid G. (CHIEF LEGAL OFFICER) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
07/05/2023 4 DOTSON JERROLD DUANE (VP, CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
01/03/2023 4 DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.0876, valued at $438
01/03/2023 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.0876, valued at $438
08/22/2022 4 GIN JERRY B (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Bought 100,000 shares @ $0.1787, valued at $17.9k
Bought 100,000 shares @ $0.1787, valued at $17.9k
08/19/2022 4 Adler Reid G. (CHIEF LEGAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Bought 300,000 shares @ $0.1697, valued at $50.9k
08/18/2022 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Bought 600,000 shares @ $0.172, valued at $103.2k
07/15/2022 4 DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.748, valued at $3.7k
07/15/2022 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.748, valued at $3.7k
07/15/2022 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.748, valued at $3.7k
07/14/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Sold 60,000 shares @ $0.89, valued at $53.4k
07/08/2022 3 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 3 on VistaGen Therapeutics, Inc.
05/16/2022 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Exercised 100,000 options to buy @ $1, valued at $100k
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/03/2022 4 DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.37, valued at $205.5k
03/03/2022 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.37, valued at $205.5k
03/03/2022 4 Cunningham Ann Michelle (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.37, valued at $205.5k
03/03/2022 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $1.37, valued at $411k
03/03/2022 4 GIN JERRY B (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.37, valued at $137k
03/03/2022 4 FitzPatrick Margaret M (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.37, valued at $137k
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Rotunno Mary L. (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.37, valued at $137k
03/03/2022 4 Curley Joanne (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.37, valued at $137k
01/12/2022 4 DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Exercised 18,750 options to buy @ $1, valued at $18.8k
01/03/2022 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 2,655 shares @ $1.6575, valued at $4.4k
01/03/2022 4 DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 3,575 shares @ $1.6575, valued at $5.9k
01/03/2022 4 SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 3,623 shares @ $1.6575, valued at $6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy